Stay updated with the latest clinical-trial news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on clinical-trial topics.
New Delhi, April 4 (SocialNews.XYZ) Union Minister Dr Jitendra Singh met with International Diabetes Federation President-elect Dr Niti Pall, and the latter highlighted that Asian and African countries "are increasingly looking to India for affordable diabetes care solutions," due to leadership in supplying cost-effective vaccines, an official statement said on Saturday. Dr Singh and Dr Pall discussed indigenous biosimilar insulin production and diabetes related indigenous biomanufacturing pros ...Read More >
NEW DELHI, Apr 4 : "International Diabetes Federation" (IDF) President-elect, Dr Niti Pall, currently on India visit, called on Union Minister Dr Jitendra Singh, who is also a noted Professor of Medicine & Diabetes, and discussed, among other things, indigenous biosimilar Insulin production as well as Diabetes related indigenous biomanufacturing prospects. The meeting underscored the importance of strengthening India's capabilities in insulin manufacturing, particularly biosimilar insulins and ...Read More >
Bangalore : Emcure Pharmaceuticals Ltd., (BSE: 544210, NSE: EMCURE) has announced the price revision of its weight management drug Poviztra® (semaglutide injection) across India. The reduced price would be starting at Rs. 3,999/- per month (4 weekly doses). The innovator Semaglutide is available in a once-weekly pen device in five strengths of 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg and a maintenance dose of 2.4 mg. It comes in a state-of-the-art pen device that provides the convenience of simple admini ...Read More >
Qdenga vaccine against dengue (image is for representation purposes only) AI generated image ShowQuick Read Summary is AI-generated, newsroom-reviewed * Qdenga dengue vaccine expected to launch in India by 2026 after regulatory approval * Vaccine developed by Takeda Pharma, to be made in India with Biological E under Make-in-India * Qdenga requires two doses and protects against all dengue serotypes, including prior infections Did our AI summary help? Let us know. Switch To Beeps Mode ...Read More >
A major Chinese clinical study on ovarian cancer has been published in CA: A Cancer Journal for Clinicians, one of the world's highest-impact medical journal, marking a first for a Chinese researcher-led gynecological cancer trial, researchers said in Beijing on Sunday. The phase III FZOCUS-1 study tested fluzoparib, a PARP inhibitor developed by Chinese pharmaceutical giant Hengrui Pharma. The trial evaluated the drug as a "maintenance" therapy, treatment given to prevent cancer recurrence aft ...Read More >
Mumbai, Oct 31 (SocialNews.XYZ) Actress Deepika Padukone, who has been a strong advocate for mental health awareness, reacted to cricketer Jemimah Rodrigues' recent revelation about battling anxiety. The 'Om Shanti Om' actress, known for openly sharing her own struggles with depression in the past, praised Jemimah for her honesty and courage in speaking up, highlighting the importance of conversations around mental well-being in sports and beyond. Taking to her Instagram Stories, Deepika Paduko ...Read More >
New Delhi [India], October 31 (ANI): The U.S. Food and Drug Administration (FDA) has announced major steps to make it faster and less costly to develop biosimilar medicines, lower-cost "generic" alternatives to biologic drugs used to treat serious and chronic diseases. In a new draft guidance, the FDA has proposed major updates aimed at simplifying biosimilarity studies and reducing unnecessary clinical testing. The agency also launched a separate initiative to make it easier for biosimilars t ...Read More >
Stempeutics will have to meet certain regulatory milestones, he said, as the product would be made in India and sent to Japan In a first of sorts in stem cell therapy, India's Stempeutics has inked an "option licence agreement" with Japan's Medinet, a listed company focussed on regenerative medicine - to take the former's product used in treating chronic limb threatening ischemia (CLTI), to Japan. Japan is a tough regulatory market, BN Manohar, Stempeutics Chief Executive Officer told business ...Read More >
New Delhi, Oct 20 (SocialNews.XYZ) A wireless retinal implant showed potential to restore central vision in patients with advanced age-related macular degeneration (AMD), according to clinical trial results published on Monday. Advanced atrophic AMD, also known as geographic atrophy (GA), is the leading cause of irreversible blindness in older adults, affecting more than 5 million people worldwide. The study, led by researchers from the University College London, University of Pittsburgh, and ...Read More >
New Delhi, Oct 20 (PTI) India had a largely inconsistent growth in clinical research related to cancer since 2001, despite a strong economic growth, suggesting that development could be a contributing factor towards disparities among the low and middle-income countries in cancer research, according to a new study. Cancer cases and deaths are projected to surge in the coming decades with low and middle-income countries expected to bear a disproportionate burden. However, researchers, including ...Read More >
The information was shared by Union Minister Jitendra Singh, who said the antibiotic is the first molecule entirely conceptualised, developed and clinically validated in India. The antibiotic, Naphithromycin, has been developed by the Department of Biotechnology in collaboration with private pharma house Wockhardt. Citing this as an example of successful industry-academia partnership driving India's biopharmaceutical growth, the Union Minister emphasised the need to build a self-sustainable in ...Read More >
BETHESDA, Md. - Gain Therapeutics, Inc. (NASDAQ:GANX), a $69 million market cap biotech company currently trading at $1.92 per share, announced Monday that its lead drug candidate GT-02287 showed encouraging early results in a Phase 1b clinical study for Parkinson's disease patients. According to InvestingPro data, the company maintains a strong balance sheet with more cash than debt, though it's currently experiencing rapid cash burn typical of early-stage biotechs. The company presented inter ...Read More >
New Delhi, Oct 1 (PTI) India will not only attract USD 100 billion committed investments from the four-nation EFTA bloc under a trade agreement, but also look at an additional USD 150 billion, Commerce and Industry Minister Piyush Goyal said on Wednesday. He said that huge opportunities are there for companies from these four countries to invest in India. Under the India-EFTA trade and economic partnership agreement (TEPA), New Delhi has received a commitment of USD 100 billion FDI from EFTA o ...Read More >
The Union Cabinet, at a meeting chaired by Prime Minister Narendra Modi, approved the Biomedical Research Career Programme (BRCP) Phase III which will be implemented by the Department of Biotechnology and Wellcome Trust, UK through the India Alliance at a cost of ₹1,500 crore over the next six years beginning 2025-26. The contribution of the Department of Biotechnology will be ₹1,000 crore and the Wellcome Trust, UK will bring in ₹500 crore. The BRCP was launched in 2008-09 for biomedical ...Read More >
MUMBAI, Sept 25 (Reuters) - Eli Lilly (LLY.N), opens new tab plans to bring its experimental oral weight-loss drug orforglipron to India as it sees market potential in the world's most populous nation, a senior executive said on Thursday. "I do think there is promise for products like that (orforpligron) in India, if it does get approved," Winselow Tucker, Lilly India's president said at an event in Mumbai. Tucker, however, did not indicate when Lilly plans to launch the drug. The drugmaker h ...Read More >
Srinagar -- In what could be a miracle improving and saving thousands of lives across the globe, Russia's mRNA-based vaccine Enteromix has displayed 100% efficacy and safety in early clinical trials. Scientists say the breakthrough could mark a new chapter in the fight against aggressive cancers, offering patients hope where few options exist. For decades, cancer has been one of humanity's most formidable enemies. Conventional treatments like chemotherapy and radiation, while sometimes life-sav ...Read More >
NEW DELHI: India accounts for 17% of the world's population and 20% of the global disease burden, yet fewer than four percent of international clinical trials are conducted in the country. This gap means Indian patients often wait years after global approvals to access breakthrough therapies. Now, a new initiative, aligning it with Central Drugs Standard Control Organisations (CDSCO) priorities to boost participation of government sites in Phase 3 and 4 trials, has trained nearly 400 professio ...Read More >
Apple Watch's hypertension detection feature has secured FDA clearance and will roll out globally from September 15 via watchOS 26. Apple has received FDA clearance for its new hypertension alerts feature on the Apple Watch, with the rollout scheduled to begin on September 15 through watchOS 26. First announced alongside the Apple Watch Series 11 and Apple Watch Ultra 3, the feature will also be available on older models including Apple Watch Series 9 and later, as well as Apple Watch Ultra 2 ...Read More >
VMPLNew Delhi [India], August 26: The Practice of Immortality, by Ishan Shivanand, was launched to a packed audience at Yashobhoomi, Delhi, on August 24, 2025, marking a watershed moment for corporate wellness. Published by Penguin Random House and Hachette Book Group across 15 countries in 4 languages (English, Italian, German, Portuguese), the book became a USA Today National Bestseller. It claimed the #1 position on Amazon India within its first week. Among the most pre-ordered and most revie ...Read More >
Raichur (Karnataka) [India], August 14: In a landmark moment for global hepatology and Indian pharmaceutical innovation, Shilpa Medicare Limited (BSE: 530661) (NSE: SHILPAMED) has secured the world first regulatory approval from India Central Drugs Standard Control Organization (CDSCO) for Nor Ursodeoxycholic Acid (NorUDCA) Tablets 500 mg, the first-ever approved therapy targeting NAFLD. * Shilpa Medicare emerges as the global pioneer to receive approval for NorUDCA, offering new hope to over a ...Read More >
Raichur (Karnataka) [India], August 14: In a landmark moment for global hepatology and Indian pharmaceutical innovation, Shilpa Medicare Limited (BSE: 530661) (NSE: SHILPAMED) has secured the world's first regulatory approval from India's Central Drugs Standard Control Organization (CDSCO) for Nor Ursodeoxycholic Acid (NorUDCA) Tablets 500 mg, the first-ever approved therapy targeting NAFLD. Also Read | 'Coolie' X Review: Rajinikanth's 'One-Man Show' With Nagarjuna's Stylish Act and Anirudh Rav ...Read More >
Raichur (Karnataka) [India], August 14: In a landmark moment for global hepatology and Indian pharmaceutical innovation, Shilpa Medicare Limited (BSE: 530661) (NSE: SHILPAMED) has secured the world first regulatory approval from India Central Drugs Standard Control Organization (CDSCO) for Nor Ursodeoxycholic Acid (NorUDCA) Tablets 500 mg, the first-ever approved therapy targeting NAFLD. * Shilpa Medicare emerges as the global pioneer to receive approval for NorUDCA, offering new hope to over a ...Read More >
New Delhi, Amid a fierce debate over the Centre's proposed integrated MBBS-BAMS course, experts have asserted that sharing of clinical exposure and research collaboration between the two specialisations is key to India establishing a gold standard in integrative healthcare. However, central to the discussion among medical professionals, educators, and policymakers is a key question: Can India successfully unify its ancient Ayurvedic medical wisdom with modern scientific practices? Dr Ajaya Kas ...Read More >
PRNewswire Chandigarh [India], July 15: Chandigarh University, India leading private university, in collaboration with job platform Apna and investment firm Venture Catalysts (VCats) have launched Campus Tank, India first university-led Startup launch-pad for young innovators below the age of 30 to pitch their ideas and get funding of $1 Million to launch their startups along with expert venture guidance, strategic ecosystem alliances and immersive startup incubation. APNA which is India larges ...Read More >
New Delhi [India], July 15 (ANI): The Supreme Court on Tuesday granted protection from arrest to Indore-based cartoonist Hemant Malviya for his objectionable caricatures of Prime Minister Narendra Modi and the Rashtriya Swayamsevak Sangh (RSS). A bench of Justices Sudhanshu Dhulia and Aravind Kumar granted interim anticipatory bail to Malviya after he submitted an apology. It directed him to file the apology in Hindi in the form of an affidavit and directed the parties to complete the pleading ...Read More >
New Delhi [India], July 14 (ANI): The Supreme Court on Monday rebuked Indore-based cartoonist Hemant Malviya for his objectionable caricatures of Prime Minister Narendra Modi and the Rashtriya Swayamsevak Sangh (RSS) while terming his conduct 'inflammatory' and 'immature.' A bench of Justices Sudhanshu Dhulia and Aravind Kumar expressed disapproval of the cartoonist's conduct saying, 'The comedians, cartoonists etc. look at their conduct...' Advocate Vrinda Grover, appearing for Malviya, said ...Read More >
New Delhi [India], July 14 (ANI): The Supreme Court on Monday rebuked Indore-based cartoonist Hemant Malviya for his objectionable caricatures of Prime Minister Narendra Modi and the Rashtriya Swayamsevak Sangh (RSS) while terming his conduct inflammatory and immature. A bench of Justices Sudhanshu Dhulia and Aravind Kumar expressed disapproval of the cartoonist conduct saying, The comedians, cartoonists etc. look at their conduct... Advocate Vrinda Grover, appearing for Malviya, said the cart ...Read More >
Representative Image: Currently, there is no antiviral treatment or licensed vaccine against dengue in India | Image: Bloomberg Enrolment of about 10,500 participants in the phase III clinical trial of the indigenous one-shot Panacea Biotec developed dengue vaccine, DengiAll, is likely to be completed by October across 20 centres in India, according to ICMR scientists. So far, 8,000 participants in various centres at Pune, Chennai, Kolkata, Delhi and Bhubaneswar among others have received eith ...Read More >
Bengaluru - Hexaware Technologies, a global provider of IT services and solutions, today announced a strategic partnership with Abluva, an innovator in agentic AI security, to address security challenges posed by autonomous AI agents in the Life Sciences industry. This collaboration brings together Hexaware's deep domain expertise and Abluva's groundbreaking Secure Intelligence Plane to help organizations in the sector deploy generative AI (GenAI) safely and in compliance with industry regulatio ...Read More >
New Delhi, July 3 (SocialNews.XYZ) None of the Covid vaccine doses are linked to heart attacks and deaths, said Dr Sudheer Arava from AIIMS, who is part of the research currently underway by the Indian Council of Medical Research (ICMR) and the All India Institute of Medical Sciences (AIIMS). Speaking to IANS, he noted that preliminary data so far has shown no indication between heart attack and Covid jabs, developed in the country. "Till now, our study data says that the vaccine has no effect ...Read More >
Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.